Ertugliflozin reduces hospitalization risk due to heart failure in diabetes Medha Baranwal25 Jun 2020 10:45 AM ISTDelhi: SGTL2 inhibitor ertugliflozin reduces heart failure hospitalization risk but does not confer a cardiovascular mortality benefit in...
Vitamin D protein impacts pancreatic function and development of type 1 diabetes Dr. Kamal Kant Kohli24 Jun 2020 11:06 PM ISTResearchers have found in a new study that Vitamin-D-binding protein (DBP) is highly expressed in pancreatic α cells affecting glucagon secretion and...
New diabetes drug lowers blood sugar without inducing vomiting, weight loss Dr. Kamal Kant Kohli24 Jun 2020 9:08 AM ISTSyracuse, NY. - Scientists at Syracuse University chemistry have developed a new drug that controls blood sugar without the common side effects of...
Heart failure significantly increases death risk in newly diagnosed diabetics Dr. Kamal Kant Kohli24 Jun 2020 8:30 AM ISTDALLAS -- Researchers have found in a new study that development of heart failure was associated with the greatest risk of death among type 2...
Study shows how COVID-19 infection influences blood sugar in type 1 diabetes Medha Baranwal23 Jun 2020 12:45 PM IST USA: Preliminary findings from a multicenter surveillance study in the U.S. has found that about half of type 1 diabetes patients with COVID-19...
Thiazolidinediones may protect diabetics from Parkinson's disease Medha Baranwal23 Jun 2020 10:30 AM ISTDelhi: Thiazolidinediones (TZDs) exhibit a neuroprotective effect against Parkinson's disease (PD) particularly in patients with type 2 diabetes...
Sexual enhancement supplement led to dangerous fall of blood sugar: A report Hina Zahid22 Jun 2020 10:45 AM ISTDr. Jennifer A. Ross at the Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, and colleagues...
Low dose Canagliflozin effectively reduces hs-CRP and CR markers in diabetes Medha Baranwal22 Jun 2020 9:00 AM ISTDelhi: Canagliflozin 100mg is as good as canagliflozin 300mg in the reduction of hs-CRP and CR markers in patients with type 2 diabetes, according to...
Golimumab may preserve beta-cell function in Type 1 diabetes: Study Hina Zahid21 Jun 2020 11:45 PM ISTBUFFALO, N.Y. - In research led by a University at Buffalo pediatric endocrinologist, a drug called Golimumab showed that it preserved beta-cell...
Susceptibility to diabetes revealed as early as eight years of age: Study Dr. Kamal Kant Kohli20 Jun 2020 9:51 AM ISTDiabetes doesn't develop overnight.It develops for many years before diagnosis.Researchers have found in a new study that early signs of being more...
SGLT2 inhibitor Bexagliflozin reduces blood sugar, high BP and weight in diabetics Medha Baranwal19 Jun 2020 5:30 PM ISTDelhi: The investigational drug Bexagliflozin was found to be well-tolerated in high-risk diabetes patients in a phase 3 study. According to the...
Novel insulin found as effective as insulin glargine in phase 2 trial Dr. Kamal Kant Kohli19 Jun 2020 1:15 PM ISTPLAINSBORO - Researchers have announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin...
